BRÈVE

sur ONWARD MEDICAL NV (isin : NL0015000HT4)

ONWARD Medical Convenes 2026 AGM in Amsterdam

ONWARD Medical N.V. has announced the convocation of its 2026 Annual General Meeting of Shareholders, scheduled for May 13, 2026, in Amsterdam, Netherlands. The neurotechnology firm, known for its work in spinal cord injury therapies, outlined several resolutions for shareholder adoption.

Key items include the adoption of the 2025 annual accounts, a vote on the compensation policy, and re-appointment of key directors. Proposals also cover the issuance of shares and appointment of EY Accountants B.V. as the external auditor for 2026. Shareholders will have the authority to acquire ordinary shares.

The record date for participation is set for April 15, 2026. Relevant details and AGM materials are available on the company's website for shareholders and US ADR holders, ensuring compliance with legal requirements.

R. P.

Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de ONWARD MEDICAL NV